28 filings · most recent first
GILD 8-K Filings
Gilead Sciences Announces Issuance Of Senior Notes
Gilead Sciences Reports Strong Q1 2026 Results And Updates Guidance
Gilead Sciences Elects New Board Members And Approves Key Proposals At 2026
Gilead Sciences Completes Acquisition Of Arcellx
Gilead Sciences To Acquire Arcellx For 78 Billion
Gilead Sciences Reports Strong 2025 Financial Results
Gilead Sciences Announces Departure Of Executive Vice President
Gilead Sciences Announces Departure Of Cao And Interim Replacement
Gilead Sciences Appoints New Chief Medical Officer
Gilead Sciences Announces Issuance Of 35B Senior Notes
Gilead Sciences Announces Departure Of Chief Medical Officer Merdad Parsey
Gilead Sciences Completes Acquisition Of Cymabay Therapeutics
Gilead Sciences Director Kevin E Lofton To Retire
Gilead Sciences Appoints Ted W Love Md To Board Of Directors
Gilead Sciences Announces Acquisition Of Cymabay Therapeutics For 43 Billion
Gilead Sciences Reports Q3 2025 Financial Results And Business Updates
Gilead Sciences Settles Patent Litigation With Generic Manufacturers
Gilead Sciences Appoints New Senior Vice President And Controller
Gilead Sciences Reports Second Quarter 2025 Financial Results And Raises
Gilead Sciences Updates Corporate Governance
Gilead Sciences Reports Voting Results From 2025 Annual Meeting
Gilead Sciences Reports Q1 2025 Financial Results
Gilead Reports Q4 And Fy 2024 Results Revenue Up Eps Down
Gilead Sciences Reports Third Quarter 2024 Financial Results
Gilead Reports 5 Revenue Growth In Q2 2024 Reiterates Fullyear Guidance
Gilead Sciences Approves Amendments And Director Elections At 2024 Annual
Gilead Announces Q1 2024 Financial Results And Strategic Updates
Gilead Sciences Reports Q4 And Full Year 2023 Financial Results